25.04.2024 08:20:57 - dpa-AFX: *HIKMA PHARMA STILL EXPECTS FY CORE OPERATING PROFIT TO BE $660 MLN TO $700 MLN

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
HIKMA PHARMACEUTIC.LS-,10 A0HG69 Frankfurt 22,600 03.10.24 19:49:46 -0,400 -1,74% 0,000 0,000 22,800 22,600

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH